Login
Companies $NAUT
$2.13 +$0.03 (1.43%) After hours
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

nautilus.bio

What Do They Do?

Develops a platform for measuring proteins and provides sample-analysis services to academic institutions, research laboratories, and biopharmaceutical companies.

How Do They Make Money?

No revenue reported yet.

Who Are Their Customers?

Academic institutions, research organizations, and biopharmaceutical companies engage with Nautilus through collaborations and Early Access services. Planned platform sales are direct in the United States and direct or through distributors elsewhere.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
vs $0 in Q3 FY2025
Net income
▼ −15% (Loss)
vs −$13.6M in Q3 FY2025

Early-access services Moved from planning an early-access phase to offering sample-analysis services for selected customers, beginning with a tau proteoform assay; broader platform commercialization remains a later step.

Who Do They Compete With?

Competes with Thermo Fisher Scientific, Bruker, Agilent Technologies, Danaher, Becton, Dickinson, Quanterix, and Illumina

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support